Related Experiment Video

Updated: May 11, 2026

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.4K

Regulation of CAR transgene expression to design semiautonomous CAR-T

Paweł Głowacki1, Cezary Tręda1,2, Piotr Rieske1,2

  • 1Department of Tumor Biology, Chair of Medical Biology, Medical University of Lodz, Zeligowskiego 7/9 Street, 90-752 Lodz, Poland.

Molecular Therapy. Oncology
|August 26, 2024
PubMed

Insights

CAR-T cell therapy relies on transgene expression. This review compares constitutive and inducible promoters, highlighting their impact on efficacy and manufacturing, and introduces advanced systems for enhanced safety and control.

Area of Science:

  • Biotechnology
  • Immunotherapy
  • Synthetic Biology

Background:

  • Effective transgene expression is crucial for genetically engineered cell therapies like CAR-T.
  • Current CAR-T therapies utilize constitutive promoters, which can affect antitumor efficacy and manufacturing.
  • Next-generation CAR-T approaches are exploring inducible promoters and autonomous expression systems for improved control and safety.

Purpose of the Study:

  • To review and categorize various constitutive and inducible promoters used in CAR-T cell therapy.
  • To compare the advantages, disadvantages, and clinical applications of different promoter systems.
  • To explore advanced expression systems, including logic gates for engineered cellular responses.

Main Methods:

  • Literature review and categorization of constitutive and inducible promoters.
  • Comparative analysis of promoter characteristics, including clinical usage.
  • Elaboration on synthetic biology tools like Synthetic Notch for signal-responsive gene expression.

Main Results:

  • Constitutive promoters influence CAR-T cell antitumor effectiveness and manufacturing processes.
  • Inducible and autonomous expression systems offer new possibilities for CAR-T cell priming, boosting, and safety.
  • Synthetic Notch-based logic gates enable coupling external signals with cellular responses.

Conclusions:

  • Promoter selection is a critical factor in CAR-T cell therapy design and performance.
  • Advanced promoter strategies and synthetic biology tools enhance the potential of CAR-T cell therapies.
  • Future CAR-T development can leverage sophisticated expression control for improved therapeutic outcomes.
Keywords:
CAR promoterCAR transcriptionCAR transgenesCAR-T exhaustionCAR-T side effectsantigen escapeautonomous CARcytokine release syndromeon-target off-tumor

More Related Videos

Generation of Human Chimeric Antigen Receptor Regulatory T Cells10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

471

Related Concept Videos

Transgenic Organisms00:53

Transgenic Organisms

Overview
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...